ClinicalTrials.gg
RecruitingNCT04780646Updated Oct 25, 2023

Effects of Urban Nature on Stress and Quality of Life

An interventional study of Nature therapy in urban nature and City Walk in Stress, Psychological, sponsored by Charite University, Berlin, Germany. Recruiting at 1 site in Germany. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2023-10-25.

Sponsored by Charite University, Berlin, Germany · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2024, 2 years 1 month ago, but the record still lists the study as recruiting.
  • Started Jun 2022; still recruiting 4 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
93
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Stress, Psychological with a site in Germany — 6 open to participants now, 7 under way, none of them phase 3. Stress, Psychological · Germany.

Planned enrollment
9th of 19
93 · median 90
Started
2022
the only one that year
No phase
19 of 27
2 open now
Registered
18th of 27
by date
Lead sponsor
8 of 27
Charite University, Berlin, Germany

Among the 27 studies in Stress, Psychological with a site in Germany, this one is the 9th largest by planned enrollment of the 19 interventional ones that give a count, is the only one that started in 2022, is one of 19 with no phase, and was the 18th registered.

Stress, Psychological

854 studies on the registry are indexed under Stress, Psychological; 141 are open to participants now.

Browse Stress, Psychological studies →

Open to participants now

6 of the 27 studies in Stress, Psychological with a site in Germany are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 74 Stress, Psychological studies recruiting now, 34 (46%) set no upper age limit and 36 (49%) stop at 75 or younger; 13 take children under 18; 49 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Stress, Psychological with a site in Germany, or all of them as a file.
02

Study summary

The aim of this study is to investigate the effects of regular nature therapy in urban nature with guidance of a licensed nature therapist on stress, quality of life and physical symptoms of subjects with elevated stress levels.

03

Conditions studied

  • Stress, Psychological

Browse trials for

Keywords

  • Nature therapy
  • Stress
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • stress with at least 4 of 10 points on the Numeric Analogue Scale (NAS) at least 1 month
  • at least 3 of the following 8 stress-associated symptoms: sleep disturbances, inappetence or increased appetite, shoulder neck tension/back pain, tension headache, concentration disturbances, exhaustion, nervousness/irritability, stress-associated digestive complaints.

Exclusion criteria

Exclusion Criteria:

  • serious acute or chronic diseases
  • pregnancy or lactation
  • known serious mental illness
  • immobility or restriction for gymnastics exercises due to orthopaedic, neurological or other medical cause
  • participation in another study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
93 participants (estimated)

Study arms

  • Experimental
    Nature therapy in urban nature

    Subjects receive a 90-minute nature therapy session once per week for 8 weeks with a licensed nature therapist, who explains exercises on perceiving nature and the connection between nature and health.

    Behavioral: Nature therapy in urban nature

  • Active comparator
    City Walk

    Subjects receive a 90-minute city walk through urban sourroundings once per week for 8 weeks with a city guide, who talks about city architecture and gives information about the history of the surroundings.

    Behavioral: City Walk

  • No intervention
    Waiting List

    Subjects don't receive any therapy.

Interventions

  • BehavioralNature therapy in urban nature

    Nature therapy means visits in nature, actively perceiving the flora and fauna

  • BehavioralCity Walk

    City Walk means walking through urban surroundings (houses, streets, concrete..) with as little as possible contact to nature

06

What researchers measure

Primary outcomes

  1. Stress questionnaire (Cohen Perceived Stress Scale, CPSS)

    Change from Baseline in the CPSS, range from 0 to 4 in each item. Scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 \& 4 = 0) to the positively stated items and then summing across all scale items while higher values meaning a higher grade of perceived stress.

    Time frame: Date of Inclusion (Baseline), after 8 weeks and after 16 weeks

Secondary outcomes

  1. Zerssen symptom list (B-LR and B-LR')

    Assessing full scale, range 20-80, higher score meaning a better outcome

    Time frame: Date of Inclusion (Baseline), after 8 weeks and after 16 weeks

  2. International Physical Activity Questionnaire (IPAQ)

    MET minutes represent the amount of energy expended carrying out physical activity. To get a continuous variable score from the IPAQ (MET minutes a week) we will consider walking to be 3.3 METS, moderate physical activity to be 4 METS and vigorous physical activity to be 8 METS; higher score meaning better outcome; range 0 to around 3000 MET minutes a week

    Time frame: Date of Inclusion (Baseline), after 8 weeks and after 16 weeks

  3. Maslach Burnout Inventory (MBI)

    Assessing full scale, range 0-96, higher score meaning a better outcome

    Time frame: Date of Inclusion (Baseline), after 8 weeks and after 16 weeks

  4. Mindfulness (Freiburger Fragebogen zur Achtsamkeit, FFA)

    Assessing full scale, range 0-56, higher score meaning a better outcome

    Time frame: Date of Inclusion (Baseline), after 8 weeks and after 16 weeks

  5. General Self-Efficacy Short Scale-3 (GSE-3)

    Time frame: Date of Inclusion (Baseline), after 8 weeks and after 16 weeks

  6. Perceived Benefits of Nature Questionnaire (PBNQ)

    mean score of the 11 items, range 1-7, lower score meaning a better outcome

    Time frame: Date of Inclusion (Baseline), after 8 weeks and after 16 weeks

  7. Subjective Vitality Scale (SVS-G state)

    Assessing full scale, range from 0-28, lower score meaning a better outcome

    Time frame: Date of Inclusion (Baseline), after 8 weeks and after 16 weeks

  8. Flourishing Scale (FS)

    Assessing full scale, range 8-56, higher score meaning a better outcome

    Time frame: Date of Inclusion (Baseline), after 8 weeks and after 16 weeks

  9. Hospital Anxiety and Depression Scale (HADS)

    Time frame: Date of Inclusion (Baseline), after 8 weeks and after 16 weeks

  10. Profile of Mood States (POMS)

    Time frame: Date of Inclusion (Baseline), after 8 weeks and after 16 weeks

  11. Sociodemographic Measurements

    Age, gender, marital status, number of people in household, education level, employment status, job, personal net income, household income

    Time frame: Date of Inclusion (Baseline)

  12. Behavioural questions: doctor visits and health

    amount of doctor visits, amount of sick leave days in the last 2 months

    Time frame: Date of Inclusion (Baseline), after 8 weeks and after 16 weeks

  13. Expectation questions

    for intervention 1 and 2 on a 6-point likert scale from 1 (very strong) to 6 (nothing at all)

    Time frame: Date of Inclusion (Baseline)

  14. Behavioural questions: cigarette consumption

    Number of cigarettes on average per day in the last month

    Time frame: Date of Inclusion (Baseline), after 8 weeks and after 16 weeks

  15. Behavioural questions: alcohol consumption

    Number of alcoholic beverages on average per week in the last month

    Time frame: Date of Inclusion (Baseline), after 8 weeks and after 16 weeks

  16. Behavioural questions: time in nature

    amount of hours spent in nature per week in the last month

    Time frame: Date of Inclusion (Baseline), after 8 weeks and after 16 weeks

  17. Behavioural questions: nature as priority

    if spending time in nature is seen as a priority on a 6-point likert scale 1 (very strong) to 6 (nothing at all)

    Time frame: Date of Inclusion (Baseline), after 8 weeks and after 16 weeks

  18. Heart Rate (HR)

    24h measuring by faros 180

    Time frame: Date of inclusion (baseline), after 8 weeks, after 16 weeks

  19. Heart Rate Variability (HRV)

    24h measuring by faros 180

    Time frame: Date of inclusion (baseline), after 8 weeks, after 16 weeks

Other outcomes

  1. Qualitative interviews in individual interviews

    Qualitative assessment will be carried out in 45-minute individual interviews in 20 (randomized selected) patients participating in the study. The interviews will be recorded, transcribed and analyzed with qualitative content analysis.

    Time frame: 8 weeks after inclusion

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2022 (actual). Primary completion is estimated for Oct 2024, 27 months after the start.

Of 462 non-industry interventional studies with no phase under Stress, Psychological, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 27 months is above that.

Counting every sponsor, half of 475 studies reached it within 13 months; a quarter within 5 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 22, 2021
First posted
Mar 3, 2021
StartActual
Jun 29, 2022
Primary completionEst.
Oct 15, 2024
CompletionEst.
Dec 15, 2024
Last update
Oct 25, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04780646
Responsible party
Andreas Michalsen (Prof. Dr., Charite University, Berlin, Germany) — Principal investigator
First posted
Mar 3, 2021
Start date
Jun 29, 2022
Primary completion
Oct 15, 2024 (estimated)
Completion
Dec 15, 2024 (estimated)
Last update
Oct 25, 2023

Study contacts

Miriam Rösner
Contact
m.roesner@immanuel.de
00493080505682
Andreas Michalsen, Prof. Dr.
principal investigator · Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion